Articles Published in 2011

Amgen names Bradway to board of directors

Friday, October 14, 2011 11:03 AM

Amgen has named Robert A. Bradway to its board of directors. Bradway is Amgen's president and chief operating officer. The addition of Bradway brings the number of Amgen board members to 13.

More... »

Oncobiologics signs two agreements worth $80 million

Thursday, October 13, 2011 12:50 PM

Oncobiologics has signed two major agreements. The first is with Parilis Biopharmaceuticals, an early-stage biotech company, and involves worldwide licensing for an undisclosed biotherapeutic product. The second is with a US based pharmaceutical company to conduct research focused on solving issues related to downstream processing of monoclonal antibodies. The identity of the client firm was not disclosed due to confidentiality terms in the agreement. The combined value of the agreements to Oncobiologics totals close to $80 million.

More... »

Echo Therapeutics launches diabetes study

Thursday, October 13, 2011 12:31 PM

Echo Therapeutics has initiated a clinical study of its Symphony tCGM System in patients with type 1 and type 2 diabetes. The company expects to complete and announce the results of the study in the fourth quarter, and plans to subsequently begin a separate study in critical care patients.

More... »

deCODE, Pfizer ink research agreement

Thursday, October 13, 2011 10:45 AM

deCODE genetics has entered into a research collaboration with Pfizer to discover sequence variants associated with specific clinical phenotypes related to Systemic Lupus Erythematosis.

More... »

IDRI awarded $300k grant for TB vaccine clinical program

Thursday, October 13, 2011 10:25 AM

The Infectious Disease Research Institute (IDRI) has been awarded a two-year $300,000 grant from The Paul G. Allen Family Foundation to support IDRI's launch of a phase I clinical trial of its new tuberculosis vaccine known as ID93/GLA-SE.  The phase I trial will evaluate the safety and immunogenicity of ID93/GLA-SE in a group of healthy volunteers, and is expected to begin in early 2012.

More... »

Anavex names executive director

Wednesday, October 12, 2011 11:52 AM

Anavex Life Sciences has named Dr. George Tidmarsh executive director. 

More... »

Oncobiologics names Canute to board of directors

Wednesday, October 12, 2011 11:31 AM

Oncobiologics has named Scott Canute to its board of directors.

More... »

Progentior Labs voted Best Emerging Biotech

Wednesday, October 12, 2011 11:13 AM

Progenitor Labs, the biotechnology company spun out of Plasticell in 2011, is pleased to announce it has been voted Best Emerging Biotech at the Oxford Biotechnology Network’s Annual Awards Dinner held at Pembroke College, Oxford. Progenitor was selected from the biotechnology companies clustered within the “Golden Triangle” comprising London, Oxford and Cambridge.

More... »

Quintiles opens European headquarters in UK

Wednesday, October 12, 2011 10:42 AM

Quintiles has officially opened its new European headquarters in Reading, United Kingdom, bringing together employees from each of its four disciplines.

More... »

EID Parry acquires Valensa International

Wednesday, October 12, 2011 10:26 AM

E.I.D.-Parry (India), the bioproducts and nutraceutical division of the Murugappa Group, has announced the acquisition of 100% of the voting shares of U. S. Nutraceuticals (Valensa International). Valensa will continue to operate as a limited liability company based in Eustis, Florida (USA), with Dr. Rudi E. Moerck as its president and CEO.

More... »